| Income Statement |
| Total Revenue | 1.33M |
|
| Revenues (USD) | 1.33M |
| Cost of Revenue | 479.26K |
| Gross Profit | 852.81K |
| Operating Expenses | 4.12M |
| Research and Development Expense | 192.44K |
| Selling, General and Administrative Expense | 2.94M |
| Operating Income | -3.27M |
| Interest Expense | 1.69K |
| Net Income | -3.17M |
| Net Income Common Stock | -3.17M |
| Net Income Common Stock (USD) | -3.17M |
| Consolidated Income | -3.17M |
| Earnings per Basic Share | -0.15 |
| Earnings per Basic Share (USD) | -0.15 |
| Earnings per Diluted Share | -0.15 |
| Earning Before Interest & Taxes (EBIT) | -3.17M |
| Earning Before Interest & Taxes (USD) | -3.17M |
| Weighted Average Shares | 20.52M |
| Weighted Average Shares Diluted | 20.52M |
| Balance Sheet |
| Cash and Equivalents | 10.23M |
| Cash and Equivalents (USD) | 10.23M |
| Trade and Non-Trade Receivables | 1.25M |
| Current Assets | 12.38M |
| Property, Plant & Equipment Net | 359.67K |
| Total Assets | 13.53M |
| Debt Current | 16.48K |
| Total Debt | 162.48K |
| Current Liabilities | 1.41M |
| Debt Non-Current | 146.00K |
| Total Liabilities | 1.56M |
| Accumulated Retained Earnings (Deficit) | -34.54M |
| Shareholders Equity | 11.97M |
| Shareholders Equity (USD) | 11.97M |
| Assets Non-Current | 1.15M |
| Total Debt (USD) | 162.48K |
| Deferred Revenue | 203.77K |
| Goodwill and Intangible Assets | 781.55K |
| Inventory | 757.45K |
| Liabilities Non-Current | 146.00K |
| Trade and Non-Trade Payables | 962.50K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 88.95K |
| Net Cash Flow from Financing | -1.60M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.57M |
| Capital Expenditure | -90.14K |
| Issuance (Purchase) of Equity Shares | -1.60M |
| Issuance (Repayment) of Debt Securities | -4.56K |
| Net Cash Flow from Investing | -90.14K |
| Net Cash Flow from Operations | -2.88M |
| Share Based Compensation | 1.32M |